Advaxis Overview

  • Founded
  • 2002
Founded
  • Status
  • Public
  • Employees
  • 35
Employees
  • Stock Symbol
  • ADXS
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.59
  • (As of Thursday Closing)

Advaxis General Information

Description

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 305 College Road East
  • Princeton, NJ 08540
  • United States
+1 (609) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Advaxis Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.59 $0.60 $0.21 - $1.48 $36.6M 62.7M 1.25M -$1.40

Advaxis Financials Summary

In Thousands,
USD
TTM 31-Jul-2020 FY 2019 31-Oct-2019 FY 2018 31-Oct-2018 FY 2017 31-Oct-2017
EV 13,973 (33,934) (447) 50,219
Revenue 254 20,884 6,063 12,031
EBITDA (28,492) (15,514) (65,541) (97,387)
Net Income (30,197) (16,612) (66,515) (93,435)
Total Assets 40,019 45,257 62,267 93,642
Total Debt 6,230 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Advaxis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Advaxis‘s full profile, request access.

Request a free trial

Advaxis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, developme
Biotechnology
Princeton, NJ
35 As of 2019
00000
000000000 00000

0000000

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna al
0000 000000000
Watertown, MA
00 As of 0000
00000
000000000 00000

000000 0

ure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000000000000
PA
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Advaxis Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Selecta Biosciences Formerly VC-backed Watertown, MA 00 00000 000000000 00000
000000 00000000000 Corporation PA 000 000.00 00000000 000.00
00000 Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
00000000 000000000 Formerly VC-backed Bedford, MA 000 00000 00000000 00000
00000 000000000 Corporation Lund, Sweden 00 00000 000000000 00000
You’re viewing 5 of 42 competitors. Get the full list »

Advaxis Executive Team (14)

Name Title Board Seat Contact Info
Kenneth Berlin JD Chief Executive Officer & Board Member
Molly Henderson Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Andres Gutierrez Ph.D Chief Medical Officer & Executive Vice President
You’re viewing 3 of 14 executive team members. Get the full list »

Advaxis Board Members (9)

Name Representing Role Since
00000 000000000 00.0 Self Chairman & Board Member 000 0000
00000 000000 00.0 Advaxis Board Member & Vice Chairman 000 0000
0000000 000000 00 Advaxis Chief Executive Officer & Board Member 000 0000
0000000 000000 00 Self Board Member 000 0000
0000 00000 Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Advaxis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Advaxis Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 12-Nov-2004 000000000000000000 Holding Companies
To view Advaxis’s complete acquisitions history, request access »